Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.21%||62.24||1.0%||$521.82m|
|VRTX||Vertex Pharmaceuticals, Inc.||3.02%||254.17||1.9%||$450.04m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.47%||655.01||2.6%||$404.30m|
|SNSS||Sunesis Pharmaceuticals, Inc.||13.90%||2.13||0.7%||$148.89m|
|EXAS||EXACT Sciences Corp.||-3.33%||50.55||17.7%||$132.03m|
|BMRN||BioMarin Pharmaceutical, Inc.||-0.53%||77.32||4.2%||$97.55m|
|TXG||10X Genomics, Inc.||-2.79%||46.30||0.0%||$89.30m|
Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firmâ€™s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimerâ€™s disease, Parkinsonâ€™s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.